Ethical investments are primarily about taking stakes in companies that have a positive social impact. However, an investment’s financial profitability should also be carefully evaluated.
Fund managers are still accountable to their investors, and they have to ensure that profits will be made even from ethical equities. This is exactly the point of Australian Ethical Investment (AEF) in taking stakes in some New Zealand companies. It chooses businesses that promote positive impacts in areas like health and environment, but it also makes sure that it will make profits from the investments.
Investing in these companies have proven to be profitable for Australia’s leading ethical fund manager. According to Andy Gracey, the portfolio manager of AEF’s Australian Shares Fund, New Zealand’s equities have performed very well for the past 10 years. His fund has invested primarily in healthcare-related stocks, but it is also looking for technology-related ones, particularly in clean energy.
The Australian Shares Fund does not invest in companies that it deems bad for the society or the environment such as those in liquor, mining, and non-renewable energy sectors. However, the fund also formerly invested in fossil fuel as means of transitioning into renewable, but since 2012, it has completely divested its investments in such stocks.
Gracey said that the fund does not make any distinction between Australian and Kiwi businesses. Quality in terms of social responsibility and financial viability is always the basis for assessing investment opportunities. Approximately 10 percent of his firm’s AU$800 million fund is invested in New Zealand companies. AEF also manages the funds of some Kiwi corporations that have investments in Australian corporations.
Some of the Kiwi investments that brought the best returns to the Australian fund are in the areas of healthcare (Fisher & Paykel Healthcare), renewable energy (Mercury NZ, Meridian Energy, and Contact Energy), and sustainable technology (Vista Group and Gentrack Group).
Fisher & Paykel Healthcare is one of the long-term investments in the AEF New Zealand portfolio. The fund manager also considers it as its best-performing. It is a well-managed healthcare technology provider that focuses on respiratory ventilation support both for hospital and home use. With regards to market performance, its earnings are expected to increase by more than 62 percent in the coming years, Yahoo! Finance reported. It is currently being traded at NZ$12.94 per share. It has so far delivered about 20 percent dividends for the fund management company.
When it comes to potential growth and long-term viability, the fund manager is also betting on the renewable energy sector of New Zealand. Approximately 80 percent of its electric energy production is from renewable sources, primarily from hydropower and geothermal plants. Some emerging energy companies in the country are also focusing on other sources such as solar and wind power.
From a purely financial aspect, the long-term viability of investing in Kiwi firms seems solid. Australian socially responsible investors are likely to be attracted by the prospects of financial sustainability coupled with environmental sustainability.
Dakhla: a New Project for the Valorization of Pelagics
The Department of Maritime Fisheries continues the implementation of the development plan of small pelagic fisheries in the South Atlantic,...
Gold’s 15 Count: How Low Can it go Next Week?
This week, the FOMC has “injected” an additional $54.20 billion dollars of “liquidity” into the financial system. This is far...
A Stock Market Correction Appears to be Underway
We note the huge rise in money supply although not in our opening piece that looks at the Fed its...
Roche is Awarded the Distribution of Reagents in Soria for Two Million Euros
Roche will be the company to distribute reagents in Soria. According to the budget application, the amount for the supply...
AZ Eltif ALICrowd Co Invests One Million in the Startup Fessura through Mamacrowd
Fussera's crowdfunding campaign launched on Mamacrowd has received the endowment of AZ Eltif ALICrowd. The company will invest one million...
Biotech7 days ago
Axes Enters the Fertility Business in Spain: the Group Buys Ovoclinic Barcelona
Featured6 days ago
The Fintech Ecosystem in Colombia Exceeds 322 Companies
Business6 days ago
Cybersecurity Rising Among America’s Infrastructure Priorities
Biotech6 days ago
Genomcore Finalizes its Entry into the United Kingdom after Increasing its Turnover by 73% in 2021